Label: AFLORA- multivitamin tablet

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated July 1, 2025

If you are a consumer or patient please visit this version.

  • DESCRIPTION

    Aflora is a prescription multivitamin/multimineral dietary supplement.

  • INDICATIONS & USAGE

    Aflora is a prescription multivitamin/multi-mineral dietary supplement formulated for the clinical dietary management of a subuoptimal nutritional status in patients where advanced folate, vitamin B supplementa­tion, and maintenance of good health is needed.

  • CONTRAINDICATIONS

    Aflora is contraindicated in patients with a known hypersensitivity to any of the ingredients.

  • PRECAUTIONS

    Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

  • WARNINGS

    WARNING Accidental overdose of iron-containing products is a leading cause of fatal poising in children under 6. Keep this product out of the reach of children. In the case of accidental overdose, call a doctor or poison control center immediately.

  • ADVERSE REACTIONS

    Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You should call your doctor for medical advice about serious adverse events. To reports adverse side effects or to obtain product information, contact Oncora Pharma at 888-321-2821.

  • DOSAGE & ADMINISTRATION

    One tablet daily or as directed by a physician.

  • HOW SUPPLIED

    Bottles of 30 Tablets (85477-904-30). Tablet is light blue, oblong.

  • SPL UNCLASSIFIED SECTION

    *Oncora Pharma does not represent this products code to be National Drug Code
    (NDC). Products codes are formatted according to standard industry practice, to meet the
    formatting requirement by pedigree reporting and supply-chain control including
    pharmacies.
    This products is a prescription-folate with or without other dietary ingredients the - due to
    increased folate levels increased risk associated with masking B12 deficiency (pernicious
    anemia) requires administration under the care of a licensed medical practitioner(64 FR
    8760). 1-3 the most appropriate way to ensure pedigree reporting consistent with these
    regulatory guidelines and safety monitoring is to dispense this product only by prescription.
    This is not an Orange Book product. This product may be administered only under a
    physician's supervision and all prescriptions using this product shall be pursuant to state
    statues as applicable. The ingredients, indication or claims of this product are not to be
    construed to be Drug claims.
    1.) Federal register Notice of August 2, 1973 (39 FR 20750)
    2.) Federal Register Notice of October 17, 1980 (45 FR 69043, 69044)
    3.) Federal register notice of March 5, 1996 (61 FR 8760)
    Storage and Handing

  • STORAGE AND HANDLING

    STORAGE: Store at 20- 25 degree C (68-77 F) excersions permitted to 15-30 degree C (59-86 F) {See USP controlled Room Temperature} Avoid excessive heat, light and moisture.


    TAMPER EVIDENT: Do not use if seal is broken or missing.


    MADE IN USA
    Distributed by:
    888-321-2821
    Oncora Pharma
    Dallas, TX 75161

  • OTHER SAFETY INFORMATION

    KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    AFLORA 
    multivitamin tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:85477-904
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FERROUS BISGLYCINATE (UNII: SFW1D987QV) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION20 mg
    POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q) POTASSIUM IODIDE0.15 mg
    PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE26 mg
    BETA CAROTENE (UNII: 01YAE03M7J) (BETA CAROTENE - UNII:01YAE03M7J) BETA CAROTENE0.3 mg
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID60 mg
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL0.1 mg
    BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04) BIOTIN0.28 mg
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1.67 mg
    CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN0.013 mg
    CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CATION80 mg
    MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION25 mg
    .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) .ALPHA.-TOCOPHEROL, DL-4.5 mg
    Inactive Ingredients
    Ingredient NameStrength
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    Product Characteristics
    ColorblueScoreno score
    ShapeOVALSize12mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:85477-904-3030 in 1 BOTTLE; Type 0: Not a Combination Product07/01/2025
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other07/01/2025
    Labeler - Oncora Pharma, LLC (119482542)